Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 799 results for "sandoz inc"

Supreme Court Hears Arguments on Appellate Standard of Review ...

The United States Supreme Court heard oral argument October 15, 2014, in Teva Pharm. USA, Inc. v. Sandoz, Inc. , No. 13-854. (The transcript and audio recording are available here .) The question before the Court in this case is whether the Federal ... JD Supra, 7 hours ago
Reuters

Supreme Court divided in battle over Teva MS drug patent

Carter Phillips (R) of the Sidley Austin firm representing Mylan Inc in the case of Teva Pharmaceuticals USA v. Sandoz, departs after arguments at the U.S. Supreme Court, October 15, 2014. Credit: Reuters/Jonathan Ernst (Reuters) - The ...
 Reuters6 days ago Questions in Teva case divides Supreme Court justices in oral arguments  Inside Counsel5 days ago U.S. Supreme Court divided on Teva patent dispute  Haaretz5 days ago Supreme Court weighs generic drug dispute  Yahoo! Singapore6 days ago
[x]  

Novartis AG's Sandoz, Inc. Will Move Into Former Novo Nordisk A/S Headquarters In New Jersey

PLAINSBORO — The former home of Novo Nordisk, a Danish pharmaceutical company that has sat vacant along Route 1 for more than a year, will soon have a new tenant and new job opportunities. Sandoz Inc., a major pharmaceutical company that ...
 BioSpace3 weeks ago

Novartis : CONTRACT AWARD - 65-- Oxazepam Capsules Sandoz, Inc Effective: 9/22/2014 - 9/21/2015 (+ 4 one year options)

Notice Type: CONTRACT AWARD Posted Date: 12-SEP-14 Office: VA National Acquisition Center Location: DEPARTMENT OF VETERANS AFFAIRS NATIONAL ACQUISITION CENTER Office Address: DEPARTMENT OF VETERANS AFFAIRS , VA NATIONAL ACQUISITION ...
 4 Traders1 month ago

Momenta Reveals Necuparanib Data for Pancreatic Cancer

Momenta Pharmaceuticals, Inc. ( MNTA ) announced top-line results from the part A portion of a phase I/II study evaluating necuparanib for the treatment of advanced metastatic pancreatic cancer. In the part A portion of the study, patients were ...
 Yahoo! Finance1 week ago
[x]  

UPDATE 1-Amgen's Humira copy succeeds in skin disease trial

(Adds analyst comment, background; updates shares) Oct 8 (Reuters) - Amgen Inc said its copycat version of AbbVie Inc's blockbuster biotech drug Humira showed comparable safety and ability to generate immune response in patients with a type of ...
 CNBC1 week ago Amgen's Humira Copy Succeeds in Plaque Psoriasis Trial  General Medicine eJournal1 week ago Amgen's Humira copy succeeds in skin disease trial  Reuters India1 week ago
[x]  

PharmaDerm launches onychomycosis medication in US

PharmaDerm, a dermatology business of Sandoz, has launched KERYDIN topical solution, 5%, for the treatment of onychomycosis of the toenails, in US. KERYDIN is developed by Anacor Pharmaceuticals, Inc. In July 2014, Sandoz announced an agreement with ...
 Individual.com3 weeks ago Anacor's Kerydin Launched in the US for Onychomycosis  Yahoo! Finance4 weeks ago Anacor Announces U.S. Launch Of KERYDIN Topical Solution, 5%  RTTNews.com4 weeks ago

Apricus Biosciences Announces Notice of Allowance of U.S. Patent Application for RayVa(TM)

SAN DIEGO, Oct. 13, 2014 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines to meet the needs of patients, today announced that the United States Patent and Trademark Office ...
 BizWire Express1 week ago Apricus Biosciences, Inc. (APRI) Developing Novel Health Solutions  InvestorIdeas.com2 weeks ago Apricus Biosciences To Present At The 13th Annual BIO Investor Forum  TheStreet.com2 weeks ago APRICUS BIOSCIENCES : Announces Notice of Allowance of U.S. Patent Application for RayVa(TM)  4 Traders1 week ago
[x]  

Anacor Pharmaceuticals, Inc. Announces Proposed Offering of $70 Million of Convertible Senior Notes Due 2021

Anacor Pharmaceuticals, Inc. ( NASDAQ:ANAC ) announced today that it intends to offer, subject to market and other considerations, $70,000,000 aggregate principal amount of Convertible Senior Notes due 2021 (the Convertible ...
 Street Sweeper1 week ago Anacor Pharmaceuticals Inc. Announces Proposed Offering of $70 Million of Convertible Senior Notes Due 2021  PharmiWeb1 week ago Anacor Pharmaceuticals Announces Commercial Launch of KERYDIN (tavaborole) Topical Solution 5% in the United States  PharmiWeb4 weeks ago ANACOR PHARMACEUTICALS : Announces Commercial Launch of KERYDIN (tavaborole) Topical Solution, 5% in the United States  4 Traders4 weeks ago
[x]  

Alexion Announces the Passing of Max Link, Ph.D., Chairman of the Company's Board of Directors

Alexion Pharmaceuticals, Inc. ( NASDAQ:ALXN ) today announced that Max Link, Ph.D., Chairman of the Board of Directors of Alexion, passed away unexpectedly on October 5 while traveling on business. Dr. Link, a globally respected ...
 Franklin Credit Management Corporation2 weeks ago ALEXION PHARMACEUTICALS : Announces the Passing of Max Link, Ph.D., Chairman of the Company's Board of Directors  4 Traders2 weeks ago Celsion : Announces The Unexpected Passing Of Max E. Link, Ph.D., Chairman Of The Board  4 Traders1 week ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less